![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
_a474b8a4-5165-462f-971e-82825299f66b.png?alt=media)
If you're considering an allogeneic stem cell transplant for your AML, this HealthTree University unit is for you. We asked the experts questions about what it's like to undergo an allogeneic stem cell transplant so you can be prepared for the experience. You can visit HealthTree University and watch all the units we have released so far:
What is HealthTree University for AML?
HealthTree University is the world’s only online curriculum designed to help you understand all the ins and outs of AML, and is taught by the top AML experts in the world. We film the experts answering all of your basic (and not so basic) questions about AML. Today we are excited to be able to share with you a unit all about allogeneic stem cell transplant. HealthTree for AML is a living, evolving curriculum that will be continually updated as we ask AML experts the questions that matter the most to you.
Watch the Allogeneic Stem Cell Transplant Unit
8.01 - What is an allogeneic transplant?
8.02 - Do high-risk patients do transplant immediately?
8.03 - What is generally the upper age limit for receiving an allogeneic stem cell transplant?
8.04 - Does allogeneic transplant cure AML? What percentage of patients are cured who have an allogeneic transplant?
8.05 - How do patients find a matching donor?
8.06 - How long does it take to find a transplant donor?
8.07 - When should AML patients start the donor match process?
8.08 - Can you explain the allogeneic transplant process?
8.09 - Why do many patients not receive a transplant?
8.10 - Why do patients relapse after transplant?
8.11 - What is the role of a caregiver in the transplant setting?
8.12 - What is graft verses host disease or GVHD?
8.13 - What therapies are being studied to prevent or reduce the severity of graft veres host disease?
A Big Thank You to the AML Experts
Thank you to the AML experts who participated in this HealthTree University unit, Dr. Ragon, Dr. Jurcic, Dr. Kremyanskaya and Dr. Webster!
Looking for More AML Videos?
We will be releasing many more units throughout 2022! These videos will help you learn more about the ins and outs of AML from some of the top AML experts in the world. Check out the videos we've already released on our:
Have a question you would like answered by an AML expert? Email your question to katie@healthtree.org.
If you're considering an allogeneic stem cell transplant for your AML, this HealthTree University unit is for you. We asked the experts questions about what it's like to undergo an allogeneic stem cell transplant so you can be prepared for the experience. You can visit HealthTree University and watch all the units we have released so far:
What is HealthTree University for AML?
HealthTree University is the world’s only online curriculum designed to help you understand all the ins and outs of AML, and is taught by the top AML experts in the world. We film the experts answering all of your basic (and not so basic) questions about AML. Today we are excited to be able to share with you a unit all about allogeneic stem cell transplant. HealthTree for AML is a living, evolving curriculum that will be continually updated as we ask AML experts the questions that matter the most to you.
Watch the Allogeneic Stem Cell Transplant Unit
8.01 - What is an allogeneic transplant?
8.02 - Do high-risk patients do transplant immediately?
8.03 - What is generally the upper age limit for receiving an allogeneic stem cell transplant?
8.04 - Does allogeneic transplant cure AML? What percentage of patients are cured who have an allogeneic transplant?
8.05 - How do patients find a matching donor?
8.06 - How long does it take to find a transplant donor?
8.07 - When should AML patients start the donor match process?
8.08 - Can you explain the allogeneic transplant process?
8.09 - Why do many patients not receive a transplant?
8.10 - Why do patients relapse after transplant?
8.11 - What is the role of a caregiver in the transplant setting?
8.12 - What is graft verses host disease or GVHD?
8.13 - What therapies are being studied to prevent or reduce the severity of graft veres host disease?
A Big Thank You to the AML Experts
Thank you to the AML experts who participated in this HealthTree University unit, Dr. Ragon, Dr. Jurcic, Dr. Kremyanskaya and Dr. Webster!
Looking for More AML Videos?
We will be releasing many more units throughout 2022! These videos will help you learn more about the ins and outs of AML from some of the top AML experts in the world. Check out the videos we've already released on our:
Have a question you would like answered by an AML expert? Email your question to katie@healthtree.org.
about the author
Katie Braswell
Katie joined HealthTree as the Community Director for AML in 2021. She is a registered dietitian who previously worked at the VA hospital in Dallas, Texas where she coached veterans with blood cancer on how to use nutrition to improve their treatment outcomes and minimize cancer-related side effects. Katie is passionate about health education and patient empowerment. In her spare time, she loves to experiment with new recipes in the kitchen, spend time running outdoors and travel to new places.
